Aβ42 is the predominant form of amyloid β-protein in the brains of short-term survivors of head injury

NeuroReport

Volumn 8, Issue 6, 1997, Pages 1519-1522

  Gentleman, Stephen M ^a   Greenberg, Barry D ^b   Savage, Mary J ^b   Noori, Muna ^a   Newman, Suzanna J ^c   Roberts, Gareth W ^c   Griffin, W Sue T ^d   Graham, David I ^e  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b CEPHALON INC   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^e SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Amyloid protein; Head injury; Human; Immunocytochemistry; Vascular

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); PEPTIDE FRAGMENT;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DOWN SYNDROME; FEMALE; HEAD INJURY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEOCORTEX; PRIORITY JOURNAL; CASE CONTROL STUDY; CHEMISTRY; METABOLISM; MIDDLE AGED; SURVIVOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CASE-CONTROL STUDIES; CRANIOCEREBRAL TRAUMA; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; SURVIVORS;

EID: 0030612292     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199704140-00039     Document Type: Article

References (18)

1. Sekoe DJ. Annu Rev Neurosci 17, 489-517 (1994).
2. Goate A, Chartier-Harlin M-C, Mullan M et al. Nature 349, 704-706 (1991).
3. Rumble B, Retallack R, Hilbich C et al. N Engl J Med 320, 1446-1452 (1989).
4. Saunders AM, Strittmatter WJ, Schmechel D et al. Proc Natl Acad Sci USA 90, 8098-8102 (1993).
5. Mayeux R, Ottman R, Maestre G et al. Neurology 45, 555-557 (1995).
6. Roberts GW, Allsop D and Bruton CJ. J Neurol Neurosurg Psychiatry 53, 373-378 (1990).
7. Roberts GW, Gentleman SM, Lynch A et al. J Neurol Neurosurg Psychiatry 57, 419-425 (1994).
8. Nicoll JAR, Roberts GW and Graham DI. Nature Med 1, 135-137 (1995).
9. Suzuki N, Cheung TT, Cai X-D et al. Science 264, 1336-1340 (1994).
10. Dovey HF, Suomensaari-Chrysler S, Lieberburg I et al. Neuroreport 4, 1039-1042 (1993).
11. Iwatsubo T, Mann DMA, Odaka A et al. Ann Neurol 37, 294-299 (1995).
12. Scheuner D, Eckman C, Jensen M et al. Nature Med 2, 864-870 (1996).
13. Greenberg BD. Amyloid: Int J Exp Clin Invest 2, 195-203 (1995).
14. Graham DI, Gentleman SM, Lynch A et al. Neuropathol Appl Neurobiol 21, 27-34 (1995).
15. Savage MJ, Kawooya JK, Pinsker LR et al. Amyloid: Int J Exp Clin Invest 2, 234-240 (1995).
16. Gentleman SM, Graham DI and Roberts GW. Prog Brain Res 96, 237-246 (1993).
17. Griffin WST, Sheng JG, Gentleman SM et al. Neurosci Lett 176, 133-136 (1994).
18. Adle-Biassette H, Duyckaerts C, Wasowicz Y et al. Neurobiol Aging 17, 415-419 (1996).